Dr. Paul S. Anderson Curriculum Developer for AAMP August 2017 Advanced Applications in Medical Practice – 2017 Post-Scottsdale: Webinar - 2 Dr. Paul S. Anderson Curriculum Developer for AAMP August 2017

Post-Scottsdale AAMP Q&A As promised this is your chance as an attendee to ask post- conference questions. We appreciate those sent prior to this webinar but will take all (we can fit in) “live” as well. You can type your questions in to the question box on your “JoinMe” screen. We will start with a few previously sent questions: (c) PS Anderson 2017

Q-1 In July I asked: “How is it possible to hold your “8 part” holism model in your mind while assessing, treating or re-assessing a case?” The answer was OK – but next steps: The case was heavy in the infectious area with a lot of endo. Those areas are SLOWLY improving. It seems the GI should be addressed but should I test that or just empirically treat it? (c) PS Anderson 2017

Assessing the Breadth and Depth of Disturbance: Therapeutic integration and intensity: LOW MEDIUM HIGH First Acute Illness Early Chronic Illness Chronic Complicated Illness State Breadth and Depth of co-infection / co-morbidity etc (c) PS Anderson - www.ConsultDrA.com - 2017

Holism – The case begins: Effectors: 1. Cell Function 2. Toxin 3. Biofilm 4. Immunology 5. Endocrine 6. Psychosocial 7. Digestive – GI 8. Physical - Structural 7 1 In the beginning of a case you typically see the biggest symptom generators and need to address those and acute issues first: 2 6 8 3 5 4 (c) PS Anderson - www.ConsultDrA.com - 2017

Holism – The case progresses: Then, as you address the first issues and acute problems you reveal deeper layers to deal with. Sometimes (often actually) the whole person seems to change and what “wasn’t a problem” suddenly is. Effectors: 1. Cell Function 2. Toxin - ??????? 3. Biofilm 4. Immunology 5. Endocrine 6. Psychosocial 7. Digestive – GI - ??? 8. Physical - Structural 7 1 2 6 8 3 5 4 (c) PS Anderson - www.ConsultDrA.com - 2017

Q-2 My patients are mostly paying cash for labs. What is the best / most economical strategy for testing first and then follow up testing so it isn’t 1200.00 each test session? (c) PS Anderson 2017

Q-2 Initial labs need to be as thorough as indicated but you can focus them to some degree. Consider larger ‘panels’ for cost effectiveness on first round (i.e. DUTCH test / DNA Connexions, RBC element profile [no affiliation]… / more data per $ spent) If other provider labs have just been run (past 4-6 weeks) don’t re-run those but do fill in labs. Also see if other (insurance) provider will check basics. Follow up can be based on two prime factors and focused as needed: Symptom and overall case changes Follow up on formerly positive values you NEED data on to make clinical decisions. Is it “nice to” or “need to” have data? Inform the patient if limiting labs that you can use less lab data (or less frequent) and treat empirically BUT if changes happen that are not expected or explainable you’ll need more data. (c) PS Anderson 2017

Q-3 Just like you mentioned in the Scottsdale lectures I had a patient with an “indeterminate” ANA elevation. We started ‘hunting’ for causes and there were some we found (chronic infections, heavy metals, elevated HS-CRP and reverse T3 with low cortisol etc.) We are 3 months in and treating all main issues BUT the ANA rose about 10% at the 12 week labs: Is this OK? Does it mean the therapies are not correct? What should I watch for now and how much time should I give it? (c) PS Anderson 2017

Q-4 What is the most important thing to focus on with the patient through the “painful process” of making a change in their diet? I find this a challenge! (c) PS Anderson 2017

Q-5 I looked at ‘AAMP-Portland’ and can’t tell if it is really different than Scottsdale. If it is, how so and in what focus areas? (c) PS Anderson 2017

“21st. Century Metabolic Medicine” has three distinct daily content areas: 1. FRIDAY: Metabolomics as a prime cause of illness: Genomics, Insulin and Leptin Resistance: HOW TO TEST, ASSESS AND TREAT 2. SATURDAY: Metabolic Therapies and Cancer: CLINICAL ASSESSMENT AND TREATMENT PROTOCOLS 3. SUNDAY: Metabolic Therapies and Neurodegeneration: HOW TO USE THIS CLINICALLY (c) PS Anderson 2017

“21st. Century Metabolic Medicine” What lab testing and other assessment are required? • How do we actually do this clinically? / Does it work? • Precise protocols and steps to integrate into practice. (Dr. Anderson will share the clinical protocols and procedures from AMT). • Specific dietary and supplemental changes required for results. • Deeper discussions to translate research to better case assessment and outcomes. (c) PS Anderson 2017

Q-5 A three minute video outlining Portland speakers and content: https://www.youtube.com/watch?v=YttobnEqnq0 (c) PS Anderson 2017

Live Questions (c) PS Anderson 2017

More AAMP? Yes! We are actively planning two 2018 “live” events (Spring and Fall) Possibly an online only CME – watch for that news. Topics to be released soon! (c) PS Anderson 2017

https://aampportland.com/ Thank you! We look forward to seeing you in Portland for the AAMP CME conference series! https://aampportland.com/ (c) PS Anderson 2017